These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34579978)

  • 21. Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia.
    Geddes L; Iversen J; Wand H; Maher L
    Addiction; 2021 Mar; 116(3):525-535. PubMed ID: 32557931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine.
    Madden L; Bojko MJ; Farnum S; Mazhnaya A; Fomenko T; Marcus R; Barry D; Ivanchuk I; Kolomiets V; Filippovych S; Dvoryak S; Altice FL
    Int J Drug Policy; 2017 Nov; 49():48-53. PubMed ID: 28957756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis.
    Stone J; Degenhardt L; Grebely J; Larney S; Altice FL; Smyrnov P; Rahimi-Movaghar A; Alavi M; Young AM; Havens JR; Miller WC; Hickman M; Vickerman P
    Lancet Psychiatry; 2021 Apr; 8(4):301-309. PubMed ID: 33640039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine.
    Machavariani E; Dumchev K; Pykalo I; Filippovych M; Ivasiy R; Esserman D; Madden LM; Bromberg DJ; Haddad M; Morozova O; Ahmad B; Gómez DO; Farnum SO; Dvoriak S; Altice FL
    Contemp Clin Trials; 2024 Nov; 146():107690. PubMed ID: 39265780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid agonist treatment and the process of injection drug use initiation.
    Mittal ML; Jain S; Sun S; DeBeck K; Milloy MJ; Hayashi K; Hadland SE; Werb D
    Drug Alcohol Depend; 2019 Apr; 197():354-360. PubMed ID: 30922483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of the 2014 military conflict in the east of Ukraine and the Autonomous Republic of the Crimea among patients receiving opioid agonist therapies.
    Meteliuk A; Sazonova Y; Goldmann E; Xu S; Liutyi V; Liakh T; Spirina T; Lekholetova M; Islam Z; Ompad DC
    J Subst Use Addict Treat; 2024 May; 160():209312. PubMed ID: 38336264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV treatment cascade among people who inject drugs in Ukraine.
    Sazonova Y; Kulchynska R; Sereda Y; Azarskova M; Novak Y; Saliuk T; Kornilova M; Liulchuk M; Vitek C; Dumchev K
    PLoS One; 2020; 15(12):e0244572. PubMed ID: 33382768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada.
    Jacka B; Larney S; Degenhardt L; Janjua N; Høj S; Krajden M; Grebely J; Bruneau J
    Am J Public Health; 2020 Jan; 110(1):45-50. PubMed ID: 31725310
    [No Abstract]   [Full Text] [Related]  

  • 29. People Who Inject Drugs and have tuberculosis: Opioid Substitution Therapy improves treatment outcomes in Ukraine.
    Fomenko T; Meteliuk A; Korinchuk L; Denisiuk O; Aslanyan G; Islam Z; Zachariah R
    J Infect Dev Ctries; 2021 Sep; 15(9.1):51S-57S. PubMed ID: 34609960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the Russian invasion on opioid agonist therapy programs in Ukraine: A qualitative study.
    Dubov A; Basenko A; Dymaretskyi O; Shoptaw S
    Drug Alcohol Depend; 2024 Feb; 255():111069. PubMed ID: 38159338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial.
    Akiyama MJ; Norton BL; Arnsten JH; Agyemang L; Heo M; Litwin AH
    Ann Intern Med; 2019 May; 170(9):594-603. PubMed ID: 30959528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geographic variability in HIV and injection drug use in Ukraine: implications for integration and expansion of drug treatment and HIV care.
    Zaller N; Mazhnaya A; Larney S; Islam Z; Shost A; Prokhorova T; Rybak N; Flanigan T
    Int J Drug Policy; 2015 Jan; 26(1):37-42. PubMed ID: 25304049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re-examining provider perceptions of best pre-war practices: what elements can help opiate agonist therapy programs in Ukraine successfully survive the crisis?
    Dellamura P; Meteliuk A; Fomenko T; Rozanova J
    Front Public Health; 2023; 11():1259488. PubMed ID: 38239802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustainability of opioid agonist therapy programmes in Belarus, the Republic of Moldova, Tajikistan and Ukraine in the context of transition from Global Fund support during 2020-2023.
    Stuikyte R; Varentsov I; Malikov N; Dvoriak S; Filippovych M; Latypov A; Kralko A; Iatco A; Cook C
    Harm Reduct J; 2024 Oct; 21(1):183. PubMed ID: 39407276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic.
    Dumchev K; Dvoryak S; Chernova O; Morozova O; Altice FL
    Int J Drug Policy; 2017 Oct; 48():44-53. PubMed ID: 28800420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One size does not fit all-evolution of opioid agonist treatments in a naturalistic setting over 23 years.
    Nordt C; Vogel M; Dey M; Moldovanyi A; Beck T; Berthel T; Walter M; Seifritz E; Dürsteler KM; Herdener M
    Addiction; 2019 Jan; 114(1):103-111. PubMed ID: 30209840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why People Who Inject Drugs Voluntarily Transition Off Methadone in Ukraine.
    Rozanova J; Marcus R; Taxman FS; Bojko MJ; Madden L; Farnum SO; Mazhnaya A; Dvoriak S; Altice FL
    Qual Health Res; 2017 Nov; 27(13):2057-2070. PubMed ID: 28942704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs.
    Rosenthal ES; Silk R; Mathur P; Gross C; Eyasu R; Nussdorf L; Hill K; Brokus C; D'Amore A; Sidique N; Bijole P; Jones M; Kier R; McCullough D; Sternberg D; Stafford K; Sun J; Masur H; Kottilil S; Kattakuzhy S
    Clin Infect Dis; 2020 Oct; 71(7):1715-1722. PubMed ID: 32009165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary analysis of self-reported quality health indicators of patients on opioid agonist therapy at specialty and primary care clinics in Ukraine: A randomized control trial.
    Pashchenko O; Bromberg DJ; Dumchev K; LaMonaca K; Pykalo I; Filippovych M; Esserman D; Polonsky M; Galvez de Leon SJ; Morozova O; Dvoriak S; Altice FL
    PLOS Glob Public Health; 2022; 2(11):e0000344. PubMed ID: 36962514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
    Betts KS; Chan G; McIlwraith F; Dietze P; Whittaker E; Burns L; Alati R
    Addiction; 2016 Jul; 111(7):1214-23. PubMed ID: 26857811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.